Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
Tesaro, Inc.
Tesaro, Inc.
Ankara Etlik City Hospital
AstraZeneca
European Organisation for Research and Treatment of Cancer - EORTC
CancerCare Manitoba
Presage Biosciences
Cairo University
pharmaand GmbH
Yale University
Bristol-Myers Squibb
Rennes University Hospital
Fudan University
Japanese Gynecologic Oncology Group
Konkuk University Medical Center
Danish Breast Cancer Cooperative Group
Peregrine Pharmaceuticals
University of Alabama at Birmingham
King Faisal Specialist Hospital & Research Center
Valerio Therapeutics
Bayer
AGO Study Group
Intergroupe Francophone de Cancerologie Thoracique
Asan Medical Center
Queensland Centre for Gynaecological Cancer
Korean Gynecologic Oncology Group
Shanghai Jiao Tong University School of Medicine
University of Saskatchewan
West Japan Thoracic Oncology Group